chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Dry skin, Headache
Clinical narrative: Narrative: Pt reported frontal headache after 1st Pfizer COVDI-19 vaccine. PMH significant for insulin-dependent diabetes. Last insulin administration was last night, ate meals today, last fingerstick glucose reading was 3 days prior. Patient reported feeling dry and headache receded after water bottle was drank. Patient received 2nd dose of Pfizer 3 weeks later with no complaints.
Age: 57.0
Sex: F
Vaccine: TDAP
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 69yo male pt with hx of liver cell carcinoma due to hepatitis C virus died on 8/19/2021. pt had received covid vaccines on 2/5/21 & 3/8/21. Likely vaccines are not related to pt's death given liver cancer diagnosis.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 administered non agency facility 03/18, Pfizer, dose #2 administered non agency facility 12/17/2020 COVID swab, result: not detected 08/02 pt cc: cough, loss of taste or smell, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 08/04 COVID swab, result: detected 08/07 pt cc: cough, headache, myalgias, rhinorrhea, dyspnea on exertion and improving, gum soreness 08/09 pt cc: cough, diarrhea, headache, myalgias, left arm/ nerve pain, dyspnea on exertion 0810 pt cc: dry cough, headache, myalgias, neck pain, rhinorrhea, congestion (pt report improving) 08/18 CXR impression: No acute intrathoracic abnormality.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Headache, Myalgia, Nausea, Neck pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 administered non agency facility 03/18, Pfizer, dose #2 administered non agency facility 12/17/2020 COVID swab, result: not detected 08/02 pt cc: cough, loss of taste or smell, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 08/04 COVID swab, result: detected 08/07 pt cc: cough, headache, myalgias, rhinorrhea, dyspnea on exertion and improving, gum soreness 08/09 pt cc: cough, diarrhea, headache, myalgias, left arm/ nerve pain, dyspnea on exertion 0810 pt cc: dry cough, headache, myalgias, neck pain, rhinorrhea, congestion (pt report improving) 08/18 CXR impression: No acute intrathoracic abnormality.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain in extremity, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 administered non agency facility 03/18, Pfizer, dose #2 administered non agency facility 12/17/2020 COVID swab, result: not detected 08/02 pt cc: cough, loss of taste or smell, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 08/04 COVID swab, result: detected 08/07 pt cc: cough, headache, myalgias, rhinorrhea, dyspnea on exertion and improving, gum soreness 08/09 pt cc: cough, diarrhea, headache, myalgias, left arm/ nerve pain, dyspnea on exertion 0810 pt cc: dry cough, headache, myalgias, neck pain, rhinorrhea, congestion (pt report improving) 08/18 CXR impression: No acute intrathoracic abnormality.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Narrative:  Patient reported feeling flu like symptoms following administration of second pfizer covid vaccine. Patient went to urgent care and was contacted for follow up approximately 3 days later when she reported feeling much better.
Age: 52.0
Sex: M
Vaccine: FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Narrative: On May 11, 2021 a historical ADR of influenza allergy was reported by Health Technician but no other detailed information was provided Unable to find influenza immunization record in the facility system
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Urticaria
Clinical narrative: Narrative:  Patient reported hives and some SOB approximately 2 weeks after receiving vaccine. Unclear if the vaccine was the cause given the time frame.
Age: 58.0
Sex: F
Vaccine: FLUX
Symptoms: Lip swelling, Pyrexia, Urticaria
Clinical narrative: Narrative: A 57yo female On September 18, 2020 a PCC nurse reported the patient had an influenza vaccine induced historical ADR of urticaria, fever and lip swelling which influenza virus vaccine injection the patient received and when was not specified
Age: 37.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 38.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 82.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Influenza like illness
Clinical narrative: Narrative:  pt received first dose shingrix on 4/5/18. after 2nd dose on 7/9/18 c/o flu like symptoms.
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Musculoskeletal stiffness, Neck pain, Pain in extremity
Clinical narrative: Narrative:  Per primary care provider: Patient had a shingles vaccine done 11/30/2018 developed ascending pain from the right arm to the neck and similar pain 3 days later on the left arm with persistent neck stiffness and headache which is progressively gotten worse today. Vital signs are stable--patient needs evaluation in the emergency room due to acute symptoms to rule out meningitis
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chills
Clinical narrative: Narrative:  chills and weakness as detailed by reporting provider
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: COVID-19 breakthrough in fully vaccinated patient.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Narrative:  Patient reported chest tightness following 2nd dose of pfizer covid vaccine. Patient also stated they had localized swelling following 1st covid vaccine. Patient was observed without improvement and local ambulance service was called. The patient was evaluated and released without further intervention. Unclear if patient had allergic reaction or panic attack/anxiety.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Narrative:  Patient developed fatigue and muscle aches following administration of covid vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Condition aggravated
Clinical narrative: Narrative:  Patient with anxiety developed anxiety symptoms following administration of Pfizer Covid Vaccine. The symptoms gradually resolved over a short time and the patient was able to leave without issue.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient developed pain at the injection site with gradual improvement following administration of Pfizer covid vaccine.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Headache
Clinical narrative: Narrative:  Patient developed flushing and headache following administration of second dose of pfizer covid vaccine. Patient required no intervention and was able to be to released after normal monitoring period.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Narrative:  Patient reported itching throat after administration of 1st dose of Pfizer covid vaccine. Patient stated this improved with drinking water. Patient denied respiratory symptoms or rashes. Patient was observed and released without any intervention.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypotension
Clinical narrative: Narrative:  Patient became hypotension and dizzy following administration of Pfizer covid vaccine. Patient was given juice and water and improved. Patient required no further intervention.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: Narrative:  Unclear what reaction patient had. It sounds as if patient may have had a vasovagal response to their Janssen covid vaccine. Reports having passed out with other vaccinations. It was not reported that patient needed any intervention.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Oropharyngeal pain
Clinical narrative: Narrative:  Patient with history of hypertension developed sore throat and elevated BP following 2nd dose of Pfizer covid vaccine. She was taken to community ER for management.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death, Endotracheal intubation, Glioblastoma, Haemorrhage
Clinical narrative: Narrative: 76yo male patient PRESENTED TO COMMUNITY ER ON 9/7/2021. Pt was admitted with Admitting Diagnosis: Glioblastoma with Hemorrhage. Pt remained inpatient at this hospital. On 9/12/2021 pt had Cardiac arrest overnight 9/12/21, Pt was intubated & on multiple drips. Pt died on 9/14/2021. Pt had received covid vaccines on 2/22/2021 & 3/22/2021. Death is not related to covid vaccines.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Insomnia, Lymphadenopathy
Clinical narrative: Headache swollen gland right axilla, insomnia Narrative:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative:  Patient developed headache following Pfizer covid vaccine. Patient required no intervention and able to leave following normal monitoring period.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Arthralgia, fatigue, chills, injection site pain Narrative:
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Narrative:  Patient developed nausea and headache following administration of Pfizer covid vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Dizziness, Fall
Clinical narrative: Narrative:  Patient felt faint following administration of Janssen covid vaccine. Patient fell to one knee, their blood glucose was checked and found to be normal. They were given some juice and observed for about 15 minutes. The patient did not improve and was taken to the emergency department for further evaluation.
Age: 100.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fall
Clinical narrative: Narrative:  82yo male pt had several falls at his community Adult Living Facility and was taken to hospital on 10/19 for a fall. Pt then presented to ER again on 10/29/21 at hospital for a fall. Pt then died at non-agency hospital on 11/2/2021. Pt's problem list: A fib BPH Bladder neck obstruction Compressing fracture L3 HTN GERD Alzheimers Hypothyroidism Pt had received covid vaccines on 3/9/2021 & 4/7/2021. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Immunisation reaction, Pyrexia, SARS-CoV-2 test positive, Vaccination failure
Clinical narrative: Narrative:  Pt covid-19 positive after 2 doses of moderna covid-19 vaccinations were given on 1/7/21 & 2/4/21. Pt with low grade fever. Pt is immunosupressed on chemotherapy for CMML diagnosis. Pt was treated with monoclonal antibody therapy in ED on 8/19/21 (with Casirivimab & Imdevimab combo) . Pt discharged home from ER after post infusion monitoring period completed. pt's chart flagged with ADR to covid vaccines as failure of vaccination to prevent infection.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Narrative; Patient reported itching sensation following administration of 1st Pfizer covid vaccine. Patient did not have any other issues and was released without any intervention needed.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site erythema, Injection site rash, Nausea, Pain
Clinical narrative: Narrative:  States she developed a low grade fever, some nausea, body aches, and fatigue. States symptoms improved, "but now I am concerned about the injection site." Patient states injection site on her L arm is red (measures approximately 2 inches x 4 inches), "with a strange rash, and other red areas around it, hard to explain." States redness has worsened overnight; other symptoms are gone. No lumps or drainage at injection site.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Narrative:  States she developed a low grade fever, some nausea, body aches, and fatigue. States symptoms improved, "but now I am concerned about the injection site." Patient states injection site on her L arm is red (measures approximately 2 inches x 4 inches), "with a strange rash, and other red areas around it, hard to explain." States redness has worsened overnight; other symptoms are gone. No lumps or drainage at injection site.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aggression, COVID-19, Cognitive disorder, Condition aggravated, Confusional state
Clinical narrative: Narrative: Patient is a 65 yo man with history of TBI, T2DM, HTN, HLD, CAD, kidney stone, cognitive-communication deficit and hydrocephalus due to 3rd ventricle, hypothyroidism and HTN, HLD presented for fever and altered mental status. He has cognitive disorder at baseline and unable to reach spouse via phone. Therefore, most of the history is obtained from the medical records and ED notes. He was brought in by wife due to worsening cognition. Per note, he was exposed on Sunday and tested positive for COVID today. He has received covid vaccination. He started fever today and started to become combative and more confused. He also had a headache. He denies dyspnea, nausea/vomiting, diarrhea, cough, weakness or urinary incontinence. Date of onset of symptoms: 9/2/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Using 2LNC for sat of 94%. Patient was initiated on Remdesivir and dexamethasone for COVID-19 infection.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, Headache, Hypoxia, Mental status changes, Pyrexia
Clinical narrative: Narrative: Patient is a 65 yo man with history of TBI, T2DM, HTN, HLD, CAD, kidney stone, cognitive-communication deficit and hydrocephalus due to 3rd ventricle, hypothyroidism and HTN, HLD presented for fever and altered mental status. He has cognitive disorder at baseline and unable to reach spouse via phone. Therefore, most of the history is obtained from the medical records and ED notes. He was brought in by wife due to worsening cognition. Per note, he was exposed on Sunday and tested positive for COVID today. He has received covid vaccination. He started fever today and started to become combative and more confused. He also had a headache. He denies dyspnea, nausea/vomiting, diarrhea, cough, weakness or urinary incontinence. Date of onset of symptoms: 9/2/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Using 2LNC for sat of 94%. Patient was initiated on Remdesivir and dexamethasone for COVID-19 infection.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient is a 65 yo man with history of TBI, T2DM, HTN, HLD, CAD, kidney stone, cognitive-communication deficit and hydrocephalus due to 3rd ventricle, hypothyroidism and HTN, HLD presented for fever and altered mental status. He has cognitive disorder at baseline and unable to reach spouse via phone. Therefore, most of the history is obtained from the medical records and ED notes. He was brought in by wife due to worsening cognition. Per note, he was exposed on Sunday and tested positive for COVID today. He has received covid vaccination. He started fever today and started to become combative and more confused. He also had a headache. He denies dyspnea, nausea/vomiting, diarrhea, cough, weakness or urinary incontinence. Date of onset of symptoms: 9/2/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Patient with mild hypoxia with recurrent fever to 101.1 in the afternoon on 9/4/21. Using 2LNC for sat of 94%. Patient was initiated on Remdesivir and dexamethasone for COVID-19 infection.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Medical Decision Making Developed COVID with receiving COVID vaccine Patient's oxygen saturations remained in the high 90s throughout his evaluation. Patient exhibits no increased work of breathing. Given patient's BMI greater than 25 and history of hypertension he qualifies for monoclonal antibody treatment. I discussed monoclonal antibody treatment with the patient and he is agreeable to receiving it at this time. Patient provided with infusion and monitored for 1 hour at conclusion of infusion. Patient demonstrates no evidence of adverse reaction.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: COVID-19 breakthrough in patient fully vaccinated with Pfizer
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Fatigue
Clinical narrative: Narrative: Patient developed fatigue, SOB, and anxiety following administration of covid vaccine. She was transferred to ambulance and taken to ER for further workup. Follow up revealed no acute issues, pt experienced sob and fatigue and was still recovering over a week after having the vaccine.
Age: 97.0
Sex: M
Vaccine: VARCEL
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Narrative:  First stroke on 5/22/2021, second stroke on 6/18/2021 and sent to hospital
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Clostridium difficile infection, Dyspnoea, Feeling abnormal, Organising pneumonia
Clinical narrative: Narrative: Patient was diagnosed with Covid ON 3/20/2020. He was admitted to hospital on 3/20/20 and was subsequently transferred to another hospital where he remained until discharge on 3/29/20. Patient has Crohn's Disease and is currently taking Mycophenolate 1500 mg by mouth twice a day. This is the reason the patient was approved to receive his 3rd Covid shot. He received his 1st Covid shot on 2/23/21. He received his 2nd Covid shot on 3/25/21. On 7/28/21, patient was admitted to hospital with c. diff infection and possible right knee gouty arthritis. It was thought the patient's immunocompromised state led to the c.diff. Patient was prescribed vancomycin oral capsules x 10 days. Patient received 3rd Covid shot on 9/21/21. Patient notified his primary care provider on 9/3/21 that he felt like a "truck hit him." Patient reported a rash on his arm, chest, and back. Patient arrived to the facility on 9/3/21 at 2: 30pm where an urgent care provider noted the patient was dyspneic, and  had a flat, red rash spreading from the site of the 3rd Moderna vaccine. Due to hi risk status (patient was treated for cryptogenic organizing pneumonia in the past at the hospital. Patient was transferred to another hospital were they discharged him that very same day. On 9/7/21, patient was contacted by the facility for follow up and he stated that he was feeling better but that his arm was still a little sore and he still had a rash present.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Rash erythematous
Clinical narrative: Narrative: Patient was diagnosed with Covid ON 3/20/2020. He was admitted to hospital on 3/20/20 and was subsequently transferred to another hospital where he remained until discharge on 3/29/20. Patient has Crohn's Disease and is currently taking Mycophenolate 1500 mg by mouth twice a day. This is the reason the patient was approved to receive his 3rd Covid shot. He received his 1st Covid shot on 2/23/21. He received his 2nd Covid shot on 3/25/21. On 7/28/21, patient was admitted to hospital with c. diff infection and possible right knee gouty arthritis. It was thought the patient's immunocompromised state led to the c.diff. Patient was prescribed vancomycin oral capsules x 10 days. Patient received 3rd Covid shot on 9/21/21. Patient notified his primary care provider on 9/3/21 that he felt like a "truck hit him." Patient reported a rash on his arm, chest, and back. Patient arrived to the facility on 9/3/21 at 2: 30pm where an urgent care provider noted the patient was dyspneic, and  had a flat, red rash spreading from the site of the 3rd Moderna vaccine. Due to hi risk status (patient was treated for cryptogenic organizing pneumonia in the past at the hospital. Patient was transferred to another hospital were they discharged him that very same day. On 9/7/21, patient was contacted by the facility for follow up and he stated that he was feeling better but that his arm was still a little sore and he still had a rash present.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Alpha-1 anti-trypsin normal, Antinuclear antibody negative, Arthralgia, Asymptomatic COVID-19, Neck pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/31 , Pfizer, dose #1 01/21, Pfizer, dose #2 04/06 COVD swab, result: not detected 07/19 Patient reports prior COVID-19 Diagnosis (Private sector) 07/21 visit to ED for right sided jaw pain around the mandibular molar tooth and radiate to right neck/shoulder area, xq1 day. 08/03 COVID, result: defected 08/03 pt cc: no symptoms exposure: unknown 08/04 clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in jaw, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/31 , Pfizer, dose #1 01/21, Pfizer, dose #2 04/06 COVD swab, result: not detected 07/19 Patient reports prior COVID-19 Diagnosis (Private sector) 07/21 visit to ED for right sided jaw pain around the mandibular molar tooth and radiate to right neck/shoulder area, xq1 day. 08/03 COVID, result: defected 08/03 pt cc: no symptoms exposure: unknown 08/04 clinically resolved
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Abdominal pain lower, Abdominal tenderness, Alanine aminotransferase increased, Amylase increased
Clinical narrative: Narrative: 50 yo M. PMH - CAD s/p AMI/PCI 2010, HFrEF 2/2 ischemic cardiomyopathy s/p ICD, known diverticulosis, HTN, HLD. Presented to ER this afternoon w/ "congestion" and LLQ abd pain. Abdominal pain started on Thursday night after dinner, after which he describes having non-bloody diarrhea. Pain is 10/10, constant, sharp and located in LLQ: it radiates just below the umbilicus. It is minimally relieved with a heating pad; exacerbated by movement. Endorses chills, loss of appetite, nausea, and dysuria. Denies vomiting. Congestion (rhinorrhea, sore throat) started within the past week. Poommate was diagnosed with to COVID-19 over the weekend and subsequently exposed the patient. Patient has been fully vaccinated. In the ER, pt was vitally stable. Physical exam was remarkable for diffuse abdominal tenderness, worse in LLQ and obvious discomfort upon moving. Labs remarkable for elevated lipase, amylase, and ALT. CXR without acute cardiopulmonary changes, but with small amount of free air under the R hemidiaphragm. CT Abd noted perforated sigmoid diverticulitis. Surgery consulted in ER and, given hemodynamic stability, recommended conservative medical management. Admitted to MICU for observation and serial abdominal exams in setting of perforated diverticulitis. Patient never required supplemental oxygen nor treatment for COVID-19. patient was discharged home on antibiotics for perforated sigmoid diverticulitis.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Computerised tomogram abdomen abnormal, Decreased appetite
Clinical narrative: Narrative: 50 yo M. PMH - CAD s/p AMI/PCI 2010, HFrEF 2/2 ischemic cardiomyopathy s/p ICD, known diverticulosis, HTN, HLD. Presented to ER this afternoon w/ "congestion" and LLQ abd pain. Abdominal pain started on Thursday night after dinner, after which he describes having non-bloody diarrhea. Pain is 10/10, constant, sharp and located in LLQ: it radiates just below the umbilicus. It is minimally relieved with a heating pad; exacerbated by movement. Endorses chills, loss of appetite, nausea, and dysuria. Denies vomiting. Congestion (rhinorrhea, sore throat) started within the past week. Poommate was diagnosed with to COVID-19 over the weekend and subsequently exposed the patient. Patient has been fully vaccinated. In the ER, pt was vitally stable. Physical exam was remarkable for diffuse abdominal tenderness, worse in LLQ and obvious discomfort upon moving. Labs remarkable for elevated lipase, amylase, and ALT. CXR without acute cardiopulmonary changes, but with small amount of free air under the R hemidiaphragm. CT Abd noted perforated sigmoid diverticulitis. Surgery consulted in ER and, given hemodynamic stability, recommended conservative medical management. Admitted to MICU for observation and serial abdominal exams in setting of perforated diverticulitis. Patient never required supplemental oxygen nor treatment for COVID-19. patient was discharged home on antibiotics for perforated sigmoid diverticulitis.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diaphragmatic disorder, Diarrhoea, Diverticular perforation, Diverticulitis, Dysuria
Clinical narrative: Narrative: 50 yo M. PMH - CAD s/p AMI/PCI 2010, HFrEF 2/2 ischemic cardiomyopathy s/p ICD, known diverticulosis, HTN, HLD. Presented to ER this afternoon w/ "congestion" and LLQ abd pain. Abdominal pain started on Thursday night after dinner, after which he describes having non-bloody diarrhea. Pain is 10/10, constant, sharp and located in LLQ: it radiates just below the umbilicus. It is minimally relieved with a heating pad; exacerbated by movement. Endorses chills, loss of appetite, nausea, and dysuria. Denies vomiting. Congestion (rhinorrhea, sore throat) started within the past week. Poommate was diagnosed with to COVID-19 over the weekend and subsequently exposed the patient. Patient has been fully vaccinated. In the ER, pt was vitally stable. Physical exam was remarkable for diffuse abdominal tenderness, worse in LLQ and obvious discomfort upon moving. Labs remarkable for elevated lipase, amylase, and ALT. CXR without acute cardiopulmonary changes, but with small amount of free air under the R hemidiaphragm. CT Abd noted perforated sigmoid diverticulitis. Surgery consulted in ER and, given hemodynamic stability, recommended conservative medical management. Admitted to MICU for observation and serial abdominal exams in setting of perforated diverticulitis. Patient never required supplemental oxygen nor treatment for COVID-19. patient was discharged home on antibiotics for perforated sigmoid diverticulitis.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Laboratory test abnormal, Lipase increased, Nausea, Oropharyngeal pain
Clinical narrative: Narrative: 50 yo M. PMH - CAD s/p AMI/PCI 2010, HFrEF 2/2 ischemic cardiomyopathy s/p ICD, known diverticulosis, HTN, HLD. Presented to ER this afternoon w/ "congestion" and LLQ abd pain. Abdominal pain started on Thursday night after dinner, after which he describes having non-bloody diarrhea. Pain is 10/10, constant, sharp and located in LLQ: it radiates just below the umbilicus. It is minimally relieved with a heating pad; exacerbated by movement. Endorses chills, loss of appetite, nausea, and dysuria. Denies vomiting. Congestion (rhinorrhea, sore throat) started within the past week. Poommate was diagnosed with to COVID-19 over the weekend and subsequently exposed the patient. Patient has been fully vaccinated. In the ER, pt was vitally stable. Physical exam was remarkable for diffuse abdominal tenderness, worse in LLQ and obvious discomfort upon moving. Labs remarkable for elevated lipase, amylase, and ALT. CXR without acute cardiopulmonary changes, but with small amount of free air under the R hemidiaphragm. CT Abd noted perforated sigmoid diverticulitis. Surgery consulted in ER and, given hemodynamic stability, recommended conservative medical management. Admitted to MICU for observation and serial abdominal exams in setting of perforated diverticulitis. Patient never required supplemental oxygen nor treatment for COVID-19. patient was discharged home on antibiotics for perforated sigmoid diverticulitis.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Narrative: 50 yo M. PMH - CAD s/p AMI/PCI 2010, HFrEF 2/2 ischemic cardiomyopathy s/p ICD, known diverticulosis, HTN, HLD. Presented to ER this afternoon w/ "congestion" and LLQ abd pain. Abdominal pain started on Thursday night after dinner, after which he describes having non-bloody diarrhea. Pain is 10/10, constant, sharp and located in LLQ: it radiates just below the umbilicus. It is minimally relieved with a heating pad; exacerbated by movement. Endorses chills, loss of appetite, nausea, and dysuria. Denies vomiting. Congestion (rhinorrhea, sore throat) started within the past week. Poommate was diagnosed with to COVID-19 over the weekend and subsequently exposed the patient. Patient has been fully vaccinated. In the ER, pt was vitally stable. Physical exam was remarkable for diffuse abdominal tenderness, worse in LLQ and obvious discomfort upon moving. Labs remarkable for elevated lipase, amylase, and ALT. CXR without acute cardiopulmonary changes, but with small amount of free air under the R hemidiaphragm. CT Abd noted perforated sigmoid diverticulitis. Surgery consulted in ER and, given hemodynamic stability, recommended conservative medical management. Admitted to MICU for observation and serial abdominal exams in setting of perforated diverticulitis. Patient never required supplemental oxygen nor treatment for COVID-19. patient was discharged home on antibiotics for perforated sigmoid diverticulitis.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Computerised tomogram head normal, Confusional state
Clinical narrative: Narrative: 05/19/2020 COVID swab, result: not detected 10/13/2020 COVID swab, result: not detected COVID infection following COVID vaccine series: 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 04/13 pt cc: elbows and forehead itchiness 07/20 pt cc: headache, confusion, lethargy, high blood pressure 07/21 TROPONIN I result: <0.016 07/21 COVID swab, result: not detected 07/21 CT Head impression: No acute intracranial abnormality07/21 CXR impression: NO acute intracranial abnormality. 07/21 ED admission for headache and dizziness 07/27 pt cc: chills, rhinorrhea, sore throat exposure: Birthday party 08/04 COVID swab, result: detected 08/04 COVID swab, result: detected 08/05 pt cc: chills and sore throat RESOLVED, rhinorrhea IMPROVING exposure: Birthday party 08/12 SARS-COV-2 LINEAGE AY.3 08/12 SARS-COV-2 CLADE 21A DELTA
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Exposure to SARS-CoV-2, Headache, Hypertension, Laboratory test
Clinical narrative: Narrative: 05/19/2020 COVID swab, result: not detected 10/13/2020 COVID swab, result: not detected COVID infection following COVID vaccine series: 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 04/13 pt cc: elbows and forehead itchiness 07/20 pt cc: headache, confusion, lethargy, high blood pressure 07/21 TROPONIN I result: <0.016 07/21 COVID swab, result: not detected 07/21 CT Head impression: No acute intracranial abnormality07/21 CXR impression: NO acute intracranial abnormality. 07/21 ED admission for headache and dizziness 07/27 pt cc: chills, rhinorrhea, sore throat exposure: Birthday party 08/04 COVID swab, result: detected 08/04 COVID swab, result: detected 08/05 pt cc: chills and sore throat RESOLVED, rhinorrhea IMPROVING exposure: Birthday party 08/12 SARS-COV-2 LINEAGE AY.3 08/12 SARS-COV-2 CLADE 21A DELTA
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Oropharyngeal pain, Pruritus, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: 05/19/2020 COVID swab, result: not detected 10/13/2020 COVID swab, result: not detected COVID infection following COVID vaccine series: 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 04/13 pt cc: elbows and forehead itchiness 07/20 pt cc: headache, confusion, lethargy, high blood pressure 07/21 TROPONIN I result: <0.016 07/21 COVID swab, result: not detected 07/21 CT Head impression: No acute intracranial abnormality07/21 CXR impression: NO acute intracranial abnormality. 07/21 ED admission for headache and dizziness 07/27 pt cc: chills, rhinorrhea, sore throat exposure: Birthday party 08/04 COVID swab, result: detected 08/04 COVID swab, result: detected 08/05 pt cc: chills and sore throat RESOLVED, rhinorrhea IMPROVING exposure: Birthday party 08/12 SARS-COV-2 LINEAGE AY.3 08/12 SARS-COV-2 CLADE 21A DELTA
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I normal
Clinical narrative: Narrative: 05/19/2020 COVID swab, result: not detected 10/13/2020 COVID swab, result: not detected COVID infection following COVID vaccine series: 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 04/13 pt cc: elbows and forehead itchiness 07/20 pt cc: headache, confusion, lethargy, high blood pressure 07/21 TROPONIN I result: <0.016 07/21 COVID swab, result: not detected 07/21 CT Head impression: No acute intracranial abnormality07/21 CXR impression: NO acute intracranial abnormality. 07/21 ED admission for headache and dizziness 07/27 pt cc: chills, rhinorrhea, sore throat exposure: Birthday party 08/04 COVID swab, result: detected 08/04 COVID swab, result: detected 08/05 pt cc: chills and sore throat RESOLVED, rhinorrhea IMPROVING exposure: Birthday party 08/12 SARS-COV-2 LINEAGE AY.3 08/12 SARS-COV-2 CLADE 21A DELTA
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/23, Pfizer, dose #1 05/13, Pfizer, dose #2 08/04 COVID swab, result: detected 08/06 pt cc: no symptoms exposure: unknown 08/06 clinically resolved 08/12 SARS-COV-2 LINEAGE result: Bl.1.617.2 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Cerebral venous sinus thrombosis, Cerebrovascular accident, Depression, Magnetic resonance imaging head abnormal
Clinical narrative: Narrative: 3/13/2021 COVID Moderna vaccine #2 (CPVOD Moderna vaccine #1 was 2/13/2021) CVA on 4/22/2021, //cerebral venous sinus thrombosis 5/4/2021 Date Eliquis 5mg bid started: ~7/2/21, previously on dabigatran started on 5/4/21 (but did not tolerate Pradaxa) Indication: cerebral venous sinus thrombosis (CVST) Estimated duration of therapy: TBD, at least 3-4 months (Neuro continuing at least through end of Sept) Anticoagulation history: Patient diagnosed with cerebral venous sinus thrombosis 5/4/21 via MRI, Previously was started on clopidogrel 75mg daily for suspected CVA on 4/22/21. Patient experienced severe allergic rxn to clopidogrel, required and medication to stop rxn, It was during this hospitalization that pt was diagnosed with CVST. - Patient States "Depression" symptoms really started after her second dose of COVID vaccine along with neurological symptoms which lead to eventual diagnosis of cerebral venous sinus thrombosis.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom
Clinical narrative: Narrative: 3/13/2021 COVID Moderna vaccine #2 (CPVOD Moderna vaccine #1 was 2/13/2021) CVA on 4/22/2021, //cerebral venous sinus thrombosis 5/4/2021 Date Eliquis 5mg bid started: ~7/2/21, previously on dabigatran started on 5/4/21 (but did not tolerate Pradaxa) Indication: cerebral venous sinus thrombosis (CVST) Estimated duration of therapy: TBD, at least 3-4 months (Neuro continuing at least through end of Sept) Anticoagulation history: Patient diagnosed with cerebral venous sinus thrombosis 5/4/21 via MRI, Previously was started on clopidogrel 75mg daily for suspected CVA on 4/22/21. Patient experienced severe allergic rxn to clopidogrel, required and medication to stop rxn, It was during this hospitalization that pt was diagnosed with CVST. - Patient States "Depression" symptoms really started after her second dose of COVID vaccine along with neurological symptoms which lead to eventual diagnosis of cerebral venous sinus thrombosis.
Age: 88.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Bruxism, Confusional state, Death, Decreased appetite, Eating disorder
Clinical narrative: Narrative:  covid booster and influenza vaccine administered 10/27/21, patient with baseline dementia and was screening prior to administration of vaccine and was in usual state of health. Fevers presented w/in 24 hours and resolved. Patient continued with fatigue, muscle pain and decreased appetite with difficulties eating (pocketing food) which was new. Confusion increased and developed hand tremors. Five days after vaccine patient had little urine output, was hollering in pain, gritting teeth when touched by caregiver. As patient with dementia at 88 years old, treatment plan did not include returning for further hospitalization. Patient became more sedated and began sleeping almost all day, developed further mouth breathing. Hospice services were ordered, however patient passed prior to starting on 11/3/21. Caregiver denied any other changes to patients routine/medications prior to administration of vaccines.
Age: 88.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Fatigue, Hyperaesthesia, Hypersomnia, Mouth breathing, Myalgia
Clinical narrative: Narrative:  covid booster and influenza vaccine administered 10/27/21, patient with baseline dementia and was screening prior to administration of vaccine and was in usual state of health. Fevers presented w/in 24 hours and resolved. Patient continued with fatigue, muscle pain and decreased appetite with difficulties eating (pocketing food) which was new. Confusion increased and developed hand tremors. Five days after vaccine patient had little urine output, was hollering in pain, gritting teeth when touched by caregiver. As patient with dementia at 88 years old, treatment plan did not include returning for further hospitalization. Patient became more sedated and began sleeping almost all day, developed further mouth breathing. Hospice services were ordered, however patient passed prior to starting on 11/3/21. Caregiver denied any other changes to patients routine/medications prior to administration of vaccines.
Age: 88.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Pain, Pyrexia, Screaming, Tremor, Urine output decreased
Clinical narrative: Narrative:  covid booster and influenza vaccine administered 10/27/21, patient with baseline dementia and was screening prior to administration of vaccine and was in usual state of health. Fevers presented w/in 24 hours and resolved. Patient continued with fatigue, muscle pain and decreased appetite with difficulties eating (pocketing food) which was new. Confusion increased and developed hand tremors. Five days after vaccine patient had little urine output, was hollering in pain, gritting teeth when touched by caregiver. As patient with dementia at 88 years old, treatment plan did not include returning for further hospitalization. Patient became more sedated and began sleeping almost all day, developed further mouth breathing. Hospice services were ordered, however patient passed prior to starting on 11/3/21. Caregiver denied any other changes to patients routine/medications prior to administration of vaccines.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, Dyspnoea, Feeling abnormal, Intensive care, Pallor
Clinical narrative: Narrative:  Inpatient post covid vaccine given 08/02/2021 14:07- Express team event called on this patient. At appx 1727 as this RN was helping patient get dressed, he stated he didn't feel right and couldn't breath. Patient on 2L nc spo2 84. Patient was pale/gray in color around lips and nose. Oxygen level was turned up from 2L NC to 5L. express team called. PAtient has substernal retractions and auditory wheezing. RT placed on NRB, gave two duoneb treatments, drew and ABG. Pt transported to MICU for observation and further treatment if necessary. Pt had hypoxic respiratory failure post COVID vaccine. ADE flagged in pt's chart.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, Skin discolouration, Wheezing
Clinical narrative: Narrative:  Inpatient post covid vaccine given 08/02/2021 14:07- Express team event called on this patient. At appx 1727 as this RN was helping patient get dressed, he stated he didn't feel right and couldn't breath. Patient on 2L nc spo2 84. Patient was pale/gray in color around lips and nose. Oxygen level was turned up from 2L NC to 5L. express team called. PAtient has substernal retractions and auditory wheezing. RT placed on NRB, gave two duoneb treatments, drew and ABG. Pt transported to MICU for observation and further treatment if necessary. Pt had hypoxic respiratory failure post COVID vaccine. ADE flagged in pt's chart.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Bronchitis, COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 antibody test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/21/2020 , Pfizer, dose# 1 01/11/2021, Pfizer, dose #2 08/05 COVID swab, result: detected 08/05 pt cc: pt non verbal exposure: wife COVID+ 08/05 COVID swab, result: detected Severe bilateral lower lobe bronchitis without convincing bronchopneumonia. No pleural effusion. 08/10 SARS-COV-2 IgG result: 2.92 08/12 SARS-COVI-2 LINEAGE result: pending 08/12 SARS-COV-2 clade result: pending 08/12 SARS-COV-2 mutations result: pending 08/16 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/21/2020 , Pfizer, dose# 1 01/11/2021, Pfizer, dose #2 08/05 COVID swab, result: detected 08/05 pt cc: pt non verbal exposure: wife COVID+ 08/05 COVID swab, result: detected Severe bilateral lower lobe bronchitis without convincing bronchopneumonia. No pleural effusion. 08/10 SARS-COV-2 IgG result: 2.92 08/12 SARS-COVI-2 LINEAGE result: pending 08/12 SARS-COV-2 clade result: pending 08/12 SARS-COV-2 mutations result: pending 08/16 clinically resolved
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/06 Janssen, dose #1 08/03 COVID swab, result: detected 08/05 - 08/07 pt cc: loss of taste or smell, chills, cough, diarrhea, rhinorrhea, sore throat exposure: sister +COVID 08/07 clinically resolved
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Exposure to SARS-CoV-2, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/06 Janssen, dose #1 08/03 COVID swab, result: detected 08/05 - 08/07 pt cc: loss of taste or smell, chills, cough, diarrhea, rhinorrhea, sore throat exposure: sister +COVID 08/07 clinically resolved
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Haematuria, Headache, Pain
Clinical narrative: Headache headache, elevated temp, hematuria, body aches Narrative:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Pyrexia, Respiratory tract congestion
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/21, Modena, dose #1 02/19, Moderna , dose #2 08/04 COVID swab, result: detected 08/01 pt cc: cough, fatigue, fever, rhinorrhea, congestion exposure: unknow 08/01-08/12 pt's symptoms continued 08/12 SARS-COV-2 Variant Sequencing results: pending
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/21, Modena, dose #1 02/19, Moderna , dose #2 08/04 COVID swab, result: detected 08/01 pt cc: cough, fatigue, fever, rhinorrhea, congestion exposure: unknow 08/01-08/12 pt's symptoms continued 08/12 SARS-COV-2 Variant Sequencing results: pending
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Myalgia, Fatigue Narrative:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Chest X-ray abnormal, Chills, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/05, Pfizer, dose #1 02/09, Pfizer, dose #2 05/26 CXR impression: Streaky peribronchial opacities emanating from both hila may 07/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste, nausea, rhinorrhea, dyspnea, sore throat exposure: +COVID clinically resolved 08/06 COVID swab, result: detected 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21A Delta
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Lung opacity, Nausea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/05, Pfizer, dose #1 02/09, Pfizer, dose #2 05/26 CXR impression: Streaky peribronchial opacities emanating from both hila may 07/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste, nausea, rhinorrhea, dyspnea, sore throat exposure: +COVID clinically resolved 08/06 COVID swab, result: detected 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21A Delta
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/05, Pfizer, dose #1 02/09, Pfizer, dose #2 05/26 CXR impression: Streaky peribronchial opacities emanating from both hila may 07/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste, nausea, rhinorrhea, dyspnea, sore throat exposure: +COVID clinically resolved 08/06 COVID swab, result: detected 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21A Delta
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, COVID-19, Cough, Dyspnoea, Flatulence
Clinical narrative: Narrative:  8-year-old male with comorbidities of hepatitis C s/p treatment in 2/2019, ulcerative colitis, seropositive non-erosive rheumatoid arthritis, high risk medication use (tofacitinib and hydroxychloroquine) who presents to the ED with a chief complaint of dyspnea. Symptoms started, 8/28/2021. Dyspnea started yesterday and is progressively worsening. It is associated with a non-productive cough. He had an outpatient Covid test done that was positive. He was vaccinated with Moderna x2 in 1/2021 and 2/2021. No fevers or chills. Diarrhea started Thursday but seems to have slowed down. He is passing flatus. He has generalized abdominal discomfort with eating or drinking, as well as nausea. He is unsure how he contracted Covid. Wife also has Covid but is doing well. He has been taking tofacitibin and hydroxychloroquine throughout illness, up until ED visit. He was placed on 2 L NC due to tachypnea.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Illness, Nausea, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Narrative:  8-year-old male with comorbidities of hepatitis C s/p treatment in 2/2019, ulcerative colitis, seropositive non-erosive rheumatoid arthritis, high risk medication use (tofacitinib and hydroxychloroquine) who presents to the ED with a chief complaint of dyspnea. Symptoms started, 8/28/2021. Dyspnea started yesterday and is progressively worsening. It is associated with a non-productive cough. He had an outpatient Covid test done that was positive. He was vaccinated with Moderna x2 in 1/2021 and 2/2021. No fevers or chills. Diarrhea started Thursday but seems to have slowed down. He is passing flatus. He has generalized abdominal discomfort with eating or drinking, as well as nausea. He is unsure how he contracted Covid. Wife also has Covid but is doing well. He has been taking tofacitibin and hydroxychloroquine throughout illness, up until ED visit. He was placed on 2 L NC due to tachypnea.